Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.06.02.657346

A novel transformer-based platform for the prediction and design of biosynthetic gene clusters for (un)natural products

Abstract

Biosynthetic gene clusters (BGCs), comprising sets of functionally related genes responsible for synthesizing complex natural products, are a rich source of bioactive compounds with pharmaceutical potential. Here, we present a transformer-based framework that models functional domains as linguistic units to capture and predict their positional relationships within genomes. Using a RoBERTa architecture, we trained models on four progressively broader datasets: bacterial BGCs, Actinomycetes genomes, bacterial genomes, and bacterial plus fungal genomes. Evaluation using 2,492 experimentally-validated BGCs from the MIBiG database showed that more than 60% of true domains were ranked first and over 80% within the top 10 candidates. Our models also achieved classification accuracies exceeding 70% for major compound classes including polyketides (PKs) and terpenes. To explore model-guided BGC design, we compared predictions from the BGC-trained and genome-trained models using the BGC for the bacterial diterpenoid cyclooctatin as a case study. The genome-trained model uniquely predicted several domains absent from both the original BGC and the prediction by the BGC-trained model. Heterologous expression of one of those predicted domains in Streptomyces albus, together with the biosynthetic genes for cyclooctatin, yielded an unknown cyclooctatin derivative. This framework not only provides a novel BGC prediction method using machine learning but also facilitates rational design of artificial BGCs. Future integration of transcriptomic, protein structural, and phylogenetic data will enhance the models predictive and generative capabilities, supporting accelerated discovery and engineering of natural products. Author SummaryBGCs encode diverse natural products, including antibiotics and anticancer agents. Identifying and designing BGCs in microbial genomes is crucial for discovering new bioactive compounds. In this study, we developed a transformer-based deep learning model that treats protein domains as language-like tokens and learns how they are arranged in genomes. By training on both known BGCs and whole genomes, the model successfully predicts biologically plausible combinations of domains, including those absent in known BGCs. We experimentally validated one such prediction by expressing a newly identified gene alongside known cyclooctatin biosynthetic genes, confirming the production of an unknown cyclooctatin derivative. Our results demonstrate how language models can uncover hidden biosynthetic potential and offer a promising new AI tool for natural product discovery and synthetic biology.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kawano, T., Shiraishi, T., Kuzuyama, T., Umemura, M.. 2025-06-04. A novel transformer-based platform for the prediction and design of biosynthetic gene clusters for (un)natural products. https://doi.org/10.1101/2025.06.02.657346

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗